Win L. Chiou
Department of Pharmaceutics and Pharmacodynamics (M/C 865) College of Pharmacy
University of Illinois at Chicago
60612
USA
Name/email consistency: high
- Unexpected lack of effect of the rifampin-induced P-glycoprotein on the oral bioavailability of its substrate, talinolol, in humans: implication in phenotyping. Chiou, W.L., Ma, C., Wu, T.C., Jeong, H.Y. J. Pharm. Sci (2003)
- Comparison of oral absorption and bioavailablity of drugs between monkey and human. Chiou, W.L., Buehler, P.W. Pharm. Res. (2002)
- The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology. Chiou, W.L. J. Pharmacokinet. Pharmacodyn (2001)
- Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Chiou, W.L., Jeong, H.Y., Wu, T.C., Ma, C. Clin. Pharmacol. Ther. (2001)
- Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Chiou, W.L., Jeong, H.Y., Chung, S.M., Wu, T.C. Pharm. Res. (2000)
- Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice. Chiou, W.L., Chung, S.M., Wu, T.C. Pharm. Res. (2000)
- Potential role of P-glycoprotein in affecting hepatic metabolism of drugs. Chiou, W.L., Chung, S.M., Wu, T.C. Pharm. Res. (2000)
- Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Chiou, W.L., Barve, A. Pharm. Res. (1998)